Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cidara Therapeutics Inc (20D.BE)

Berlin - Berlin Delayed Price. Currency in EUR
0.5696-0.0480 (-7.77%)
At close: 09:52PM CET
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
61,294
49,572
12,067
20,915
0
Operating Expense
94,515
91,827
83,916
62,639
63,285
Operating Income
-33,221
-42,255
-71,849
-41,724
-63,285
Net Non Operating Interest Income Expense
-4
-212
-262
221
629
Other Income Expense
-
-
-
411
3,640
Pretax Income
-33,225
-42,467
-72,111
-41,092
-59,016
Net Income Common Stockholders
-33,225
-42,467
-74,873
-41,092
-69,345
Diluted NI Available to Com Stockholders
-33,225
-42,467
-74,873
-41,092
-69,345
Basic EPS
-
-0.81
-1.80
-1.41
-2.76
Diluted EPS
-
-0.81
-1.80
-1.41
-2.76
Basic Average Shares
-
52,453
41,557
29,093
25,143
Diluted Average Shares
-
52,453
41,557
29,093
25,143
Total Operating Income as Reported
-33,221
-42,255
-71,849
-41,724
-63,285
Total Expenses
94,515
91,827
83,916
62,639
63,285
Net Income from Continuing & Discontinued Operation
-33,225
-42,467
-72,111
-41,092
-59,016
Normalized Income
-33,225
-42,467
-72,111
-41,503
-62,867
Interest Expense
-
212
-
-
-
Net Interest Income
-4
-212
-262
221
629
EBIT
-33,221
-42,255
-71,849
-41,724
-63,285
EBITDA
-33,221
-
-
-
-
Reconciled Depreciation
-1,141
-1,230
229
375
523
Net Income from Continuing Operation Net Minority Interest
-33,225
-42,467
-72,111
-41,092
-59,016
Total Unusual Items Excluding Goodwill
-
-
-
411
3,851
Total Unusual Items
-
-
-
411
3,851
Normalized EBITDA
-33,221
-42,255
-71,620
-41,760
-66,613
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement